Multicenter randomized controlled trial of pediatric constraint-induced movement therapy: 6-month follow-up

Jane Case-Smith1, Stephanie C DeLuca, Richard Stevenson

  • 1Occupational Therapy Division, Ohio State University, 406 Atwell Hall, 453 West 10th Avenue, Columbus, OH 43210, USA. Jane.Case-Smith@osumc.edu

Insights

Constraint-induced movement therapy (CIMT) for pediatric unilateral cerebral palsy (CP) showed sustained improvements regardless of 3 or 6 hours daily dosage. This suggests optimal functional gains are achievable with either treatment intensity for children with CP.

Area of Science:

  • Pediatric rehabilitation
  • Neurology
  • Occupational therapy

Background:

  • Unilateral cerebral palsy (CP) significantly impacts motor function in children.
  • Constraint-induced movement therapy (CIMT) is an emerging intervention for pediatric CP.
  • Optimizing CIMT dosage for sustained functional gains requires further investigation.

Purpose of the Study:

  • To compare the maintenance of functional gains 6 months post-treatment in children with unilateral CP receiving 6 hours versus 3 hours of daily CIMT.
  • To test the hypothesis that higher daily CIMT dosage leads to greater long-term maintenance of improvements.

Main Methods:

  • A multisite randomized controlled trial (RCT) involving 18 children (ages 3-6) with unilateral CP.
  • Children were randomized to 3 or 6 hours of daily CIMT for 21 days, with a cast applied to the unaffected limb.
  • Standardized assessments (Assisted Hand Assessment, Quality of Upper Extremity Skills Test, Pediatric Motor Activity Log) were administered pre- and post-treatment, with follow-ups at 1 week, 1 month, and 6 months.

Main Results:

  • Both CIMT dosage groups demonstrated significant improvements across all measured functional outcomes.
  • No statistically significant differences in the maintenance of gains were observed between the 6-hour and 3-hour groups at the 6-month follow-up.
  • Effect sizes for pre- to post-intervention changes ranged from .33 to .80, indicating substantial improvements within both groups.

Conclusions:

  • The study confirms the sustained positive effects of pediatric CIMT on functional performance in children with unilateral CP up to 6 months post-treatment.
  • The hypothesis that a higher daily CIMT dosage (6 hours vs. 3 hours) results in superior long-term maintenance of gains was not supported.
  • These findings suggest that both 3 and 6 hours of daily CIMT are effective for achieving lasting functional improvements in pediatric unilateral CP.
Abstract

Related Concept Videos